Advanced Oncotherapy PLC

Advanced Oncotherapy maps out plans for growth following £30mln deal with Yantai CIPU

Nicolas Serandour, chief executive of Advanced Oncotherapy PLC (LON:AVO), visited the Proactive Investors studio to add some extra detail to their recent announcement that they've secured £37.4mln of fresh funding - £30mln of this coming from a new Chinese investor.

The injection will bankroll the continuing technical development of the firm’s first LIGHT system and its installation at the Harley Street Proton Therapy Centre.

Quick facts: Advanced Oncotherapy PLC

Price: £0.40

Market: LSE
Market Cap: £92.09 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Advanced Oncotherapy PLC named herein, including the promotion by the Company of Advanced Oncotherapy PLC in any Content on the Site, the...



Tertiary Minerals, Advanced Oncotherapy among Alan Green's 2018 stocks to watch

Brand Communications' Alan Green highlights his small cap stocks to watch in 2018. First on Alan's hit list is Tertiary Minerals (LON:TYM). Tertiary’s share price has been on a good run recently since it announced they'd signed an MoU with global commodities group Possehl to enter...

on 27/12/17


Second Price Monitoring Extn

2 weeks, 1 day ago

Price Monitoring Extension

2 weeks, 1 day ago

Result of AGM

3 weeks, 6 days ago

Harley Street update

4 weeks, 2 days ago

Final Results

on 28/6/19

2 min read